5 days ago
PTGX
AnalystsBrian ChengBrian Cheng's Stock Forecasts
AnalystsBrian Cheng
Sectors:
Industries:
Analyst Ranking
Top 26%
#1352 out of 5224 analysts
Average Return
+3.29%
Win Rate
46%32 out of 70
Risk vs Reward
Poor
Good
Brian Cheng's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Protagonist Therapeutics IncPTGX | +170.97% | $17.19 | $46.58 | 2023-09-24 - 2024-09-24 | Strong Buy |
Sierra Oncology IncSRRA | +143.75% | $22.56 | $54.99 | 2021-09-26 - 2022-06-30 | Strong Buy |
Protagonist Therapeutics IncPTGX | +136.16% | $38.66 | $91.30 | 2025-03-03 - 2026-03-03 | Strong Buy |
Sierra Oncology IncSRRA | +136.11% | $23.29 | $54.99 | 2021-11-29 - 2022-06-30 | Strong Buy |
Protagonist Therapeutics IncPTGX | +127.75% | $37.58 | $85.59 | 2025-02-03 - 2026-02-03 | Strong Buy |
Brian Cheng Analyst Color
Get additional color on Brian Cheng's coverage of popular stocks
Brian Cheng's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Protagonist Therapeutics IncPTGX | 7 | Strong Buy | $106.00 | +7.57% | Maintains | 5 days ago |
Protara Therapeutics IncTARA | 1 | Strong Buy | $27.00 | +423.26% | Initiates Coverage On | 20 days ago |
Eikon Therapeutics IncEIKN | 1 | Strong Buy | $29.00 | +147.65% | Initiates Coverage On | 22 days ago |
Tg Therapeutics IncTGTX | 1 | Strong Buy | $46.00 | +51.07% | Maintains | 2 months ago |
Revolution Medicines IncRVMD | 2 | Strong Buy | $122.00 | +26.25% | Maintains | 2 months ago |
Kymera Therapeutics IncKYMR | 1 | Strong Buy | $125.00 | +62.42% | Maintains | 3 months ago |
Intellia Therapeutics IncNTLA | 5 | Strong Sell | $5.00 | -61.86% | Downgrades | 5 months ago |
Xencor IncXNCR | 5 | Strong Buy | $18.00 | +49.38% | Maintains | 5 months ago |
Zymeworks IncZYME | 3 | Strong Buy | $23.00 | -4.25% | Maintains | 5 months ago |
Immunovant IncIMVT | 4 | Strong Buy | $33.00 | +35.36% | Maintains | 6 months ago |
Cg Oncology IncCGON | 2 | Strong Buy | $47.00 | -27.65% | Maintains | 6 months ago |
Roivant Sciences LtdROIV | 7 | Strong Buy | $20.00 | -28.39% | Maintains | 6 months ago |
Crispr Therapeutics AgCRSP | 1 | Strong Buy | $70.00 | +49.32% | Initiates Coverage On | 6 months ago |
Immunome IncIMNM | 3 | Strong Buy | $22.00 | +6.02% | Maintains | 8 months ago |
Blueprint Medicines CorpBPMC | 3 | Hold | $129.00 | -0.36% | Downgrades | 10 months ago |
Iteos Therapeutics IncITOS | 4 | Hold | $8.00 | -21.18% | Downgrades | 10 months ago |
Kyverna Therapeutics IncKYTX | 2 | Strong Buy | $33.00 | N/A | Maintains | 2 years ago |
Metagenomi Therapeutics IncMGX | 2 | Hold | $6.00 | N/A | Downgrades | 2 years ago |
Mersana Therapeutics IncMRSN | 3 | Hold | $125.00 | N/A | Upgrades | 2 years ago |
Allogene Therapeutics IncALLO | 3 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Editas Medicine IncEDIT | 2 | Hold | $9.00 | N/A | Maintains | 2 years ago |
Cargo Therapeutics IncCRGX | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | 2 years ago |
Bioatla IncBCAB | 3 | Strong Buy | $14.00 | N/A | Maintains | 2 years ago |
Adicet Bio IncACET | 2 | Hold | $96.00 | N/A | Downgrades | 3 years ago |
Senti Biosciences IncSNTI | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Gossamer Bio IncGOSS | 2 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Clovis Oncology IncCLVSQ | 1 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Adc Therapeutics SaADCT | 2 | Strong Buy | $5.00 | N/A | Initiates Coverage On | 4 years ago |
Poseida Therapeutics IncPSTX | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 4 years ago |
Sierra Oncology IncSRRA | 2 | Strong Buy | $39.00 | N/A | Maintains | 4 years ago |
Regulus Therapeutics IncRGLS | 2 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 5 years ago |
Arcturus Therapeutics Holdings IncARCT | 2 | Strong Buy | $85.00 | N/A | Maintains | 5 years ago |
Biocryst Pharmaceuticals IncBCRX | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.